Lightning Round: Fortress Investment, Primerica & More

Monday, 9 Sep 2013 | 6:43 PM ET
Lightning Round
Monday, 9 Sep 2013 | 6:40 PM ET
You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.

Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites.

Avanir Pharmaceuticals (AVNR): I think it's a great spec biotech, said Cramer. However, if you're long and have gains, I'd start to think about taking profits.

Fortress Investment (FIG): I had been negative on this stock, said Cramer, but they're getting it together. Going forward, I think it's a decent buy.

username | Wikipedia

HCI Group (HCI): I like the homeowner's insurance business, said Cramer. Therefore, I think this is a winner.

Primerica (PRI): It's a great long-term play on boomers retiring, said Cramer.

DaVita Healthcare Partners (DVA): I'm worried about this stock, said Cramer. They have reimbursement issues and I can't get my arms around what's going on.

Nuverra Environmental Solutions (NES): This is a play on nat gas drilling, said Cramer. Until fracking increases substantially I worry that it won't rally much.

Raptor Pharmaceutical (RPTP): This is an early-stage biotech, said Cramer. If you have gains I'd sell half. This is about as speculative as it gets.

Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com

  Price   Change %Change
Nuverra Environmental Solutions

Contact Mad Money

  • Showtimes

    Monday - Friday 6p ET
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.